Showing results (1-10 of 45) with videos related to
Sort By:
Pageof 5
Nature Reviews. Immunology|August 21, 2010
NFAT, immunity and cancer: a transcription factor comes of ageMartin R Müller, Anjana RaoMethods in Molecular Medicine|December 9, 2004
RNA transfection of dendritic cellsFrank Grünebach, Martin R Müller, Peter BrossartCancer Immunology, Immunotherapy : CII|April 20, 2005
New developments in dendritic cell-based vaccinations: RNA translated into clinicsFrank Grünebach, Martin R Müller, Peter BrossartJournal of Immunology (Baltimore, Md. : 1950)|June 10, 2003
Transfection of dendritic cells with RNA induces CD4- and CD8-mediated T cell immunity against breast carcinomas and reveals the immunodominance of presented T cell epitopesMartin R Müller, Frank Grünebach, Alessio Nencioni, et al.Blood|October 24, 2002
Induction of myeloma-specific cytotoxic T cells using dendritic cells transfected with tumor-derived RNACaterina Milazzo, Volker L Reichardt, Martin R Müller, et al.Die Ophthalmologie|April 29, 2024
[Staging and systemic treatment of ocular and periocular metastases]Daniela Dörfel, Neele Babst, Ludwig Maximillian Heindl, et al.Onkologie|January 5, 2007
Aprepitant as salvage therapy in patients with chemotherapy-induced nausea and emesis refractory to prophylaxis with 5-HT(3) antagonists and dexamethasoneKarin Oechsle, Martin R Müller, Jörg T Hartmann, et al.Blood|November 15, 2003
Induction of chronic lymphocytic leukemia (CLL)-specific CD4- and CD8-mediated T-cell responses using RNA-transfected dendritic cellsMartin R Müller, Garyfalia Tsakou, Frank Grünebach, et al.Cellular Immunology|February 5, 2020
Genetic loss of NFAT2 (NFATc1) impairs B cell development of B1 and B2 B cellsMelanie Märklin, Jonas S Heitmann, Joseph Kauer, et al.Cancer Research|June 3, 2006
BCR-ABL is not an immunodominant antigen in chronic myelogenous leukemiaFrank Grünebach, Valbona Mirakaj, Valdete Mirakaj, et al.Pageof 5